SynthesisMolecules (Basel, Switzerland)2026
Emerging Processing Technologies for Modulating Allergenic Proteins in Legumes and Gluten-Containing Cereals: A Systematic Review.
Synthesis in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Legumes and gluten-containing cereals are major sources of plant protein, but they also contain immunoreactive proteins that may resist processing and gastrointestinal digestion. This systematic review examined how emerging processing technologies affect these proteins, focusing on immunoreactivity, antigenicity, molecular structure, digestibility, techno-functional properties, and the analytical methods used to measure these responses. Searches were conducted in Scopus and the Web of Science Core Collection according to PRISMA 2020, resulting in 95 eligible studies. Soybean and wheat were the most studied matrices, representing 35% and 30% of the included studies, respectively. Most experiments were conducted in vitro and relied on enzyme-linked immunosorbent assays, Western blotting, electrophoresis, or simulated gastrointestinal digestion. Direct biological evidence was scarce. Ultrasound and irradiation were the most frequently investigated technologies, followed by microwave processing, cold plasma, extrusion, high-pressure processing, electric fields, enzymatic hydrolysis, and pH shifting. These treatments induced protein unfolding, aggregation, fragmentation, oxidation, secondary-structure rearrangement, changes in sulfhydryl-group accessibility, and shifts in digestibility and techno-functional behavior. Decreased antibody recognition was reported more consistently in legumes, especially after combined treatments. Responses in gluten-containing cereals were less predictable and ranged from partial reduction to no change or increased recognition, depending on the matrix, treatment intensity, extraction procedure, and immunological assay. Emerging technologies can therefore modify protein structure and analytical immunoreactivity. Current evidence, however, does not establish that these changes reduce clinical allergenicity or gluten-related immunogenicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.